There were 55 patients (51%) with lymph node metastasis (N1/N2) and 46 patients (42%) with elevated serum carcinoembryonic antigen (CEA) levels >5 ng/ml. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.